Krystal Biotech Inc —— 季度财务数据 (NASDAQ:KRYS) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 52.84 M30.97 M52.73 M39.66 M77.51 M 200.87 M 投资活动产生的现金 -83.78 M-54.77 M-10.53 M-4.29 M11.16 M -58.42 M 融资活动产生的现金 2.43 M-12.47 M1.8 M3.71 M15.67 M 8.71 M 自由现金流 52.04 M24.77 M50.83 M37.95 M75.37 M 188.91 M

新闻

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krystal Biotech总裁Krishnan Krish S出售价值658万美元的KRYS股票

Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock

Krystal Biotech董事Krishnan出售价值658万美元股票

Krystal Biotech director Krishnan sells $6.58 million in shares

Krystal Biotech在TD Cowen会议上:战略增长与挑战

Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges

Krystal Biotech董事Daniel Janney出售价值325万美元股票

Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million